Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AbbVie
Age
21–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participant has diagnosed cancer of pancreas with biopsy and/or radiography, with a life expectancy of at least 5 months at screening
Participant's pancreatic cancer must involve the head and/or neck of the pancreas
Confirmed exocrine pancreatic insufficiency (EPI) as evidenced by fecal elastase-1 (FE-1) ≤ 150 µg/g stool at screening
A positive Sudan stain for participants without history of fat malabsorption (fat malabsorption is defined as clinical steatorrhea, or measured stool fat \> 7 g/day, or positive stool results by Sudan stain) within 1 week of screening -- Positive stool results are defined as increased level of neutral OR total fats
You may not be if
Participant has neuroendocrine pancreatic cancer
Participant has fibrosing colonopathy
Participant has any other malignancy within 1 year of screening
Participant has uncontrolled gout, including those with a recent flare within 60 days of screening
Participant has other significant organ or bone marrow abnormality within 60 days of screening
Clareo Health | A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)
